2L
GNMX

22NW LP’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History

22NW LP’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-155,000
Closed -$195K – 83
2017
Q3 		$195K Hold
155,000
– – 0.11% 84
2017
Q2 		$206K Hold
155,000
– – 0.12% 78
2017
Q1 		$288K Buy
+155,000
New +$288K 0.17% 86